CDT Equity Inc. (CDT)Healthcare | Biotechnology | Naples, United States | NasdaqCM
3.46 USD
-0.08
(-2.260%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 3.49 +0.03 (0.728%) ⇧ (April 17, 2026, 5:48 p.m. EDT) Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:56 a.m. EDT
Extremely bearish short-term signal (Rating 0) due to a statistically significant predicted price decline of -31% over the next 45 days, compounded by a 1-for-25 reverse stock split and explicit 'going concern' risk warnings indicating imminent financial distress. The long-term outlook is equally poor (Rating 0) as the company is valueless compared to book value, trading at a negative P/E and reporting massive Free Cash Flow burn without a clear path to profitability, effectively operating as a speculative asset suitable only for deep contrarian bets. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.408043 |
| AutoTheta | 0.505336 |
| AutoETS | 0.768953 |
| MSTL | 0.800279 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 42.33 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.066 |
| Excess Kurtosis | -0.65 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 16,810,124 |
| Beta | 2.08 |
| Previous Name | Conduit Pharmaceuticals Inc. |
| Website | https://www.conduitpharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.99789536 |
| Address1 | 4,581 Tamiami Trail North |
| Address2 | Suite 200 |
| All Time High | 7,500,000.0 |
| All Time Low | 2.601 |
| Ask | 4.12 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 148,950 |
| Average Daily Volume3 Month | 85,871 |
| Average Volume | 85,871 |
| Average Volume10Days | 148,950 |
| Beta | 2.079 |
| Bid | 2.52 |
| Bid Size | 2 |
| Book Value | -77.816 |
| City | Naples |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.46 |
| Current Ratio | 0.342 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.5484 |
| Day Low | 3.19 |
| Display Name | CDT Equity |
| Earnings Timestamp End | 1,762,977,600 |
| Earnings Timestamp Start | 1,762,977,600 |
| Ebitda | -34,332,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.468 |
| Enterprise Value | 16,076,123 |
| Eps Trailing Twelve Months | -1,177.89 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.2194 |
| Fifty Day Average Change | -10.7594 |
| Fifty Day Average Change Percent | -0.7566705 |
| Fifty Two Week Change Percent | -99.789536 |
| Fifty Two Week High | 1,842.0 |
| Fifty Two Week High Change | -1,838.54 |
| Fifty Two Week High Change Percent | -0.9981216 |
| Fifty Two Week Low | 2.601 |
| Fifty Two Week Low Change | 0.85899997 |
| Fifty Two Week Low Change Percent | 0.33025756 |
| Fifty Two Week Range | 2.601 - 1842.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,648,474,200,000 |
| Free Cashflow | -775,500 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.73058 |
| Held Percent Institutions | 0.00027000002 |
| Implied Shares Outstanding | 4,858,417 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,774,569,600 |
| Last Split Factor | 1:25 |
| Long Business Summary | CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida. |
| Long Name | CDT Equity Inc. |
| Market | us_market |
| Market Cap | 16,810,124 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1772079937 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | -39,224,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 16,688,662 |
| Open | 3.5 |
| Operating Cashflow | -15,555,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 646 491 9132 |
| Post Market Change | 0.02519989 |
| Post Market Change Percent | 0.72832054 |
| Post Market Price | 3.4852 |
| Post Market Time | 1,776,462,498 |
| Prev Name | Conduit Pharmaceuticals Inc. |
| Previous Close | 3.54 |
| Price Hint | 4 |
| Price To Book | -0.04446386 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.118 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0799999 |
| Regular Market Change Percent | -2.25989 |
| Regular Market Day High | 3.5484 |
| Regular Market Day Low | 3.19 |
| Regular Market Day Range | 3.19 - 3.5484 |
| Regular Market Open | 3.5 |
| Regular Market Previous Close | 3.54 |
| Regular Market Price | 3.46 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 90,556 |
| Return On Assets | -4.6679096 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,858,417 |
| Shares Percent Shares Out | 0.0196 |
| Shares Short | 92,355 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 7,110 |
| Short Name | CDT Equity Inc. |
| Short Percent Of Float | 0.0197 |
| Short Ratio | 1.4 |
| Source Interval | 15 |
| State | FL |
| Symbol | CDT |
| Total Cash | 1,509,000 |
| Total Cash Per Share | 0.311 |
| Total Debt | 775,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1,177.89 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 127.307724 |
| Two Hundred Day Average Change | -123.847725 |
| Two Hundred Day Average Change Percent | -0.9728218 |
| Type Disp | Equity |
| Volume | 90,556 |
| Website | https://www.conduitpharma.com |
| Zip | 34,103 |